Scarica l'app Stockscreener
12.08
1.42%
0.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.92
Aprire:
$11.9
Volume 24 ore:
5.77M
Relative Volume:
5.38
Capitalizzazione di mercato:
$682.10M
Reddito:
-
Utile/perdita netta:
$-72.89M
Rapporto P/E:
-4.9917
EPS:
-2.42
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
+43.07%
1M Prestazione:
+66.29%
6M Prestazione:
+203.74%
1 anno Prestazione:
+4.58%
Intervallo 1D:
$11.90
$12.13
Intervallo di 1 settimana:
$7.85
$12.17
Portata 52W:
$3.555
$12.52
Astria Therapeutics Inc Stock (ATXS) Company Profile
Nome
Astria Therapeutics Inc
Settore
Industria
Telefono
617-349-1971
Indirizzo
22 BOSTON WHARF ROAD, BOSTON
Confronta ATXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
12.09 | 655.21M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.98 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
484.93 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.58 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.66 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.82 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Reiterato | H.C. Wainwright | Buy |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-31 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-07-29 | Iniziato | TD Cowen | Buy |
| 2023-03-28 | Iniziato | Evercore ISI | Outperform |
Astria Therapeutics Inc Borsa (ATXS) Ultime notizie
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS) - cnhinews.com
Automated trading signals detected on Astria Therapeutics Inc.July 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com
Institutional scanner results for Astria Therapeutics Inc.2025 Short Interest & Consistent Profit Alerts - newser.com
Identifying reversal signals in Astria Therapeutics Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
ATXS Faces Downgrade with Price Target Slashed by Analyst Wedbush | ATXS Stock News - GuruFocus
BioCryst Keen To Take Takeda’s HAE Crown With Astria Acquisition - insights.citeline.com
Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX - Nasdaq
Astria Therapeutics (ATXS) Downgraded by JMP Securities: Latest Analyst Insights | ATXS Stock News - GuruFocus
Astria Therapeutics: Pipeline And Market Potential Post BioCryst Acquisition - Seeking Alpha
BioCryst to buy Astria Therapeutics for $700m in enterprise value - Pharmaceutical Technology
Combining price and volume data for Astria Therapeutics Inc.Chart Signals & AI Enhanced Market Trend Forecasts - newser.com
How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals - Yahoo Finance
Oppenheimer downgrades Astria Therapeutics stock rating to Perform on BioCryst acquisition - Investing.com Canada
Astria Therapeutics (ATXS) Acquisition Sparks Interest in Naveni - GuruFocus
Low frequency sounds good to Biocryst in $700M Astria HAE buy - BioWorld MedTech
Astria Therapeutics (ATXS) Acquisition Boosts Confidence in BioC - GuruFocus
Form 425 Astria Therapeutics, Filed by: BIOCRYST PHARMACEUTICALS INC - StreetInsider
ATXS Rating Downgraded: Jefferies Lowers Price Target | ATXS Sto - GuruFocus
BioCryst to Acquire Astria in $700M Deal - USA Herald
Covington, Sidley Guide $700M BioCryst Allergic Disease Deal - Law360
Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings - Benzinga
BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate' - Benzinga
BioCryst Pharmaceuticals, Inc. agreed to acquire Astria Therapeutics, Inc. for approximately $720 million. - MarketScreener
Shareholder Alert: The Ademi Firm investigates whether Astria Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - Eastern Progress
Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today - TipRanks
BioCryst to Acquire Astria Therapeutics in $700 Million Deal - contractpharma.com
BioCryst deepens rare diseases focus with $700 million deal for Astria - Reuters
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On TuesdayAmerican Resources (NASDAQ:AREC), Albertsons Companies (NYSE:ACI) - Benzinga
ATXS Stocks Flying High: Too Late to Buy? - StocksToTrade
BioCryst To Acquire Astria Therapeutics - citybiz
BioCryst Pharmaceuticals To Acquire Astria In $700 Million Deal - Finimize
ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders - Business Wire
BioCryst to Acquire Astria Therapeutics for $700 Million Includi - GuruFocus
BioCryst Announces Acquisition of Astria Therapeutics (ATXS) at $13.00 Per Share - GuruFocus
BioCryst (BCRX) to Acquire Astria Therapeutics in $700M Deal - GuruFocus
BioCryst To Acquire Astria Therapeutics In $700M Deal - Stocktwits
BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal - Nasdaq
BioCryst to acquire Astria Therapeutics for $700 million - Investing.com
Astria Therapeutics (ATXS) Acquired by BioCryst in $700M Deal - GuruFocus
BioCryst to buy Astria Therapeutics in $700 million deal - Yahoo Finance
BioCryst To Acquire Astria Therapeutics In $700 Mln Cash-and-Stock Deal - Nasdaq
Astria Therapeutics stock soars after BioCryst acquisition announcement, BioCryst falls By Investing.com - Investing.com Canada
BioCryst Announces Merger with Astria Therapeutics - TipRanks
BioCryst to buy Astria Therapeutics for $13 per share - MSN
BioCryst to acquire Astria Therapeutics, strengthening presence in HAE, transforming growth profile - MarketScreener
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile - GlobeNewswire
What to do if you’re stuck in Astria Therapeutics Inc.July 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com
Can Astria Therapeutics Inc. stock maintain operating margins2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
How to forecast Astria Therapeutics Inc. trends using time seriesMarket Risk Report & Real-Time Buy Signal Alerts - newser.com
Published on: 2025-10-14 01:02:46 - newser.com
BioCryst proposes Astria deal; S-4 and approvals to follow - Stock Titan
Astria Therapeutics Inc Azioni (ATXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.11%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):